Active ingredient
Deferasirox NDC Codes
Deferasirox is an active ingredient in 96 finished products listed with the FDA, under 6 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Brand and generic names
- Deferasirox, Jadenu, Deferasirox Oral Granules, Deferasorox, Deferasirox oral, Exjade
- Labelers
- Ascend Laboratories, LLC, Novartis Pharmaceuticals Corporation, Aurobindo Pharma Limited, Camber Pharmaceuticals, Inc., Novadoz Pharmaceuticals LLC, Dr. Reddy's Laboratories Inc, MSN LABORATORIES PRIVATE LIMITED, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Teva Pharmaceuticals, Inc.
- Strengths
- Deferasirox 360 mg/1; Deferasirox 180 mg/1; Deferasirox 90 mg/1; Deferasirox 250 mg/1; Deferasirox 500 mg/1; Deferasirox 125 mg/1
- Dosage forms
- Tablet, For suspension, Tablet, Film coated, Granule, Tablet
- Routes
- Oral
- Drug classes (FDA established)
- Iron Chelator
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 144
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Sun Pharmaceutical Industries, Inc. | 62756-568 | 62756-0568-8362756-0568-86 | — |
| deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Sun Pharmaceutical Industries, Inc. | 62756-569 | 62756-0569-8362756-0569-86 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Ascend Laboratories, LLC | 67877-550 | 67877-0550-30 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Ascend Laboratories, LLC | 67877-549 | 67877-0549-30 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Ascend Laboratories, LLC | 67877-551 | 67877-0551-30 | — |
| Deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-412 | 62332-0412-3062332-0412-91 | — |
| deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1277 | 70710-1277-0170710-1277-03 | — |
| deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Zydus Pharmaceuticals USA Inc. | 70710-1275 | 70710-1275-0170710-1275-03 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Limited | 46708-325 | 46708-0325-30 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Limited | 46708-324 | 46708-0324-30 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Limited | 46708-326 | 46708-0326-30 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Inc. | 62332-324 | 62332-0324-30 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Inc. | 62332-325 | 62332-0325-30 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Alembic Pharmaceuticals Inc. | 62332-326 | 62332-0326-30 | — |
| Deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-410 | 46708-0410-3046708-0410-91 | — |
| Deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Limited | 46708-412 | 46708-0412-3046708-0412-91 | — |
| deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1471 | 70771-1471-0170771-1471-03 | — |
| Deferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Alembic Pharmaceuticals Inc. | 62332-410 | 62332-0410-3062332-0410-91 | — |
| deferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Zydus Lifesciences Limited | 70771-1473 | 70771-1473-0170771-1473-03 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | MSN LABORATORIES PRIVATE LIMITED | 69539-021 | 69539-0021-0669539-0021-3069539-0021-90+1 more | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | MSN LABORATORIES PRIVATE LIMITED | 69539-022 | 69539-0022-0669539-0022-3069539-0022-90+1 more | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | MSN LABORATORIES PRIVATE LIMITED | 69539-023 | 69539-0023-0569539-0023-0669539-0023-30+1 more | — |
| Deferasirox | Deferasirox 360 mg/1 | TabletOral | MSN LABORATORIES PRIVATE LIMITED | 69539-075 | 69539-0075-3069539-0075-99 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Dr. Reddy's Laboratories Inc | 43598-854 | 43598-0854-0543598-0854-3043598-0854-90 | — |
| Deferasirox | Deferasirox 360 mg/1 | TabletOral | Dr. Reddy's Laboratories Inc | 43598-851 | 43598-0851-1043598-0851-30 | — |
| Deferasirox | Deferasirox 90 mg/1 | TabletOral | Dr. Reddy's Laboratories Inc | 43598-853 | 43598-0853-1043598-0853-30 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Dr. Reddy's Laboratories Inc | 43598-855 | 43598-0855-1043598-0855-3043598-0855-90 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Dr. Reddy's Laboratories Inc | 43598-856 | 43598-0856-1043598-0856-3043598-0856-90 | — |
| Deferasirox | Deferasirox 90 mg/1 | TabletOral | MSN LABORATORIES PRIVATE LIMITED | 69539-073 | 69539-0073-3069539-0073-99 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Novadoz Pharmaceuticals LLC | 72205-389 | 72205-0389-0172205-0389-0272205-0389-03+1 more | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Novadoz Pharmaceuticals LLC | 72205-391 | 72205-0391-0172205-0391-0272205-0391-03+1 more | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Novadoz Pharmaceuticals LLC | 72205-390 | 72205-0390-0172205-0390-0272205-0390-03+1 more | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Actavis Pharma, Inc. | 45963-455 | 45963-0455-30 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Actavis Pharma, Inc. | 45963-456 | 45963-0456-30 | — |
| Deferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Bionpharma Inc. | 69452-160 | 69452-0160-13 | — |
| Deferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Bionpharma Inc. | 69452-159 | 69452-0159-13 | — |
| Deferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Bionpharma Inc. | 69452-161 | 69452-0161-13 | — |
| Jadenudeferasirox | Deferasirox 180 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0713 | 00078-0713-15 | — |
| Jadenudeferasirox | Deferasirox 360 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0720 | 00078-0720-15 | — |
| Jadenudeferasirox | Deferasirox 90 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0727 | 00078-0727-15 | — |
| Jadenudeferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0654 | 00078-0654-15 | — |
| Jadenudeferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0655 | 00078-0655-15 | — |
| Jadenudeferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0656 | 00078-0656-15 | — |
| Exjadedeferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0470 | 00078-0470-15 | — |
| Exjadedeferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0468 | 00078-0468-15 | — |
| Exjadedeferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0469 | 00078-0469-15 | — |
Deferasirox: common questions
- Which drugs contain Deferasirox?
- Deferasirox, Jadenu, Deferasirox Oral Granules, Deferasorox, Deferasirox oral, Exjade.
- Is there a J-code for Deferasirox?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.